Filing Details
- Accession Number:
- 0001209191-20-027904
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 16:26:33
- Reporting Period:
- 2020-05-06
- Accepted Time:
- 2020-05-08 16:26:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-06 | 465 | $187.53 | 15,397 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-06 | 611 | $155.57 | 16,008 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-06 | 79 | $269.41 | 15,929 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 149 | $270.51 | 15,780 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 328 | $272.40 | 15,452 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 240 | $273.53 | 15,212 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 210 | $274.41 | 15,002 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 70 | $275.17 | 14,932 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-06 | 465 | $0.00 | 465 | $187.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-06 | 611 | $0.00 | 611 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,122 | 2029-02-05 | No | 4 | M | Direct | |
| 4,281 | 2028-02-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $269.41 (range $268.97 to $269.87).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $270.51 (range $270.00 to $270.75).
- Open market sales reported on this line occurred at a weighted average price of $272.40 (range $272.03 to $272.98).
- Open market sales reported on this line occurred at a weighted average price of $273.53 (range $273.03 to $273.90).
- Open market sales reported on this line occurred5 at a weighted average price of $274.41 (range $274.05 to $274.65).
- Open market sales reported on this line occurred5 at a weighted average price of $275.17 (range $275.07 to $275.30).
- The option vests in 16 quarterly installments from 02/06/2019.
- The option vests in 16 quarterly installments from 02/06/2018.
Billionaire Hedge Funds
